The effect of granulocyte-colony stimulating factor on endothelial function in patients with myocardial infarction

Heart

Volumn 95, Issue 16, 2009, Pages 1320-1325

  Kim, Y J ^a   Shin, J I ^a   Park, K W ^a   Lee, H Y ^a   Kang, H J ^a   Koo, B K ^a   Park, B J ^a   Sohn, D W ^a   Oh, B H ^a   Park, Y B ^a   Kim, Hyo Soo ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ACUTE HEART INFARCTION; ADULT; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART INFARCTION; HUMAN; INJECTION; MALE; OLD MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STROKE; UNSPECIFIED SIDE EFFECT; VOLUNTEER;

ADULT; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES;

EID: 68149160394     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.143966     Document Type: Article

References (21)

1. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009-17.
2. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-6.
3. Chang SA, Kim HK, Lee HY, et al. Restoration of the left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction. Heart 2008;94:995-1001.
4. Valgimigli M, Rigolin GM, Cittanti C, et al. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur Heart J 2005;26:1838-45.
5. Kastrup J, Ripa RS, Wang Y, et al. Myocardial regeneration induced by granulocyte-colony stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease. Eur Heart J 2006;27:2743-54.
6. Cavallaro AM, Lilleby K, Majolino I, et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2005;25:85-9.
7. Hill JM, Syed MA, Arai AE, et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1643-8.
8. Matsubara H. Risk to the coronary arteries of intracoronary stem cell infusion and GCSF cytokine therapy. Lancet 2004;363:746-7.
9. Carstanjen D, Regenfus M, Muller C, et al. Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response. Exp Hematol 2001;29:812- 21.
10. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913-9.
11. Bussolino F, Wang JM, Defilippi P, et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989;337:471-3.
12. Kang HJ, Lee HY, Na SH, et al. Differential effect of intracoronary infusion of the mobilized peripheral blood stem cell by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC cell-DES trial. Circulation 2006;114(suppl I):I-145-I-151.
13. Celermajer DS, Sorensen KE, Gooch VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
14. Fichtlscherer S, Rosenberger G, Walter DH, et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000;102:1000-6.
15. Hingorani AD, Cross J, Kharbanda RK, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000;102:994-999.
16. Park KW, Kwon YW, Cho HJ, et al. G-CSF exerts dual effects on endothelial cells - opposing actions of direct eNOS induction versus indirect CRP elevation. J Mol Cell Cardiol 2008;45:670-8.
17. Ueda K, Takano H, Haseqawa H, et al. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler Thromb Vasc Biol 2006;26:e108-13.
18. Doshi SN, Naka KK, Payne N, et al. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci 2001;101:629-35.
19. Guthikonda S, Sinkey CA, Haynes WG. What is the most appropriate methodology for detection of conduit artery endothelial dysfunction? Arterioscler Thromb Vasc Biol 2007;27:1172-6.
20. Vogel RA, Corretti MC, Plotnick GD. A comparison of brachial artery flow-mediated vasodilation using upper and lower arm arterial occlusion in subjects with and without coronary risk factors. Clin Cardiol 2000;23:571-5.
21. Black MA, Cable NT, Thijssen DH, et al. Importance of measuring time course of flow-mediated dilatation in humans. Hypertension 2008;51:203-10.